News 2010-12
In December 2010, Redeye placed 25 percent of the outstanding shares in InDex Pharmaceutical on two private investors.
InDex Pharmaceuticals develops innovative drugs for the treatment of diseases within a variety of therapeutic areas, including inflammation and cancer.
For more information, contact:
Richard Goldman, Head of Corporate Finance
+46 761 84 11 11
richard.goldman@redeye.se
About Redeye
Redeye AB is a specialist investment banking boutique that focuses on small and mid-cap growth companies in the Nordic region. We focus on the IT, life sciences, media, betting, clean tech and commodities sectors. We provide services within Corporate Broking, Corporate Finance, equity research, investor relations and media services. Our strengths are our award-winning research and analysis department, experienced advisers, a unique investor network, and powerful distribution channel redeye.se. Redeye was founded in 1999 and since 2007 has been subject to the supervision of the Swedish Financial Supervisory Authority.